Medical Communications

Regeneron is facing a single man-sized obstacle in plans to expand operations at its campus in Limerick, Ireland with a …

Israeli drug development firm VBL Therapeutics has been left reeling after it announced that its lead oncology product ofranergene obadenovec, …

A team of researchers at the Minneapolis Veterans Affairs Health Care System has found that, for all their risks, opioids …

Reviled pharma bro Martin Shkreli is experiencing another heavy dose of karma after a US judge ordered him to forfeit …

A new report has canvassed the intentions of industry players in the use of real world data and evidence over …

We’re already into March and, trying to put a bad start to the year behind them on Alzheimer’s research, the …

Generics and speciality pharma firm Endo International has revealed that it has been granted a preliminary injunction to block  competitor …

A decade-long study has unearthed findings that could entirely change how people living with diabetes are treated, after the classic …

A high-ranking C-level executive of a US biotech start-up has been charged with embezzling almost $1 million from the company …

Novartis has announced an agreement between Pear Therapeutics and itself to develop two digital therapeutics, one in schizophrenia and one …

Immediately following the release of impressive full year financials, Ipsen CEO David Meek speaks on how the company is hitting …

Just two weeks ago, Merck KGaA and Pfizer were hit with a major setback for their PD-L1 immunotherapy, Bavencio, after …

The EMA, following on from the FDA’s lead earlier this month, has announced that it will revise its guidelines on …

Though never truly out of vogue, the drug pricing debate has flared up again with the White House’s release of …

The UK Government has announced plans to increase prescription charges by 20p, or 2.3%, to a record £8.80, effective 1 …